Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Femasys Inc

FEMY ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$2.29

▲ +0.00%

Market Cap $18.40M · Vol 28.21K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$18.40M

Micro Cap

Div Yield

N/A

EPS Growth

+46.59%

YoY

RSI (14)

22.70

Momentum

Beta

-2.08

vs Market

52W High

$22.20

89.68% below

52W Low

$2.20

4.09% above

Volume

28.21K

Avg 24.00K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

96.04%

Public shares

Shariah Compliance8 STANDARDS

✗ Femasys Inc (FEMY) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does FEMY pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-13.91%

-36.39%

-69.92%

-77.47%

YTD

-80.13%

-84.58%

-72.21%

-98.38%

Financials & Valuation

TTM · Annual

Total Revenue	$2.29M
Net Income	$-18,627,890.00
Revenue Growth (YoY)	-18.92%
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-112.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	+46.59%
Outstanding Shares	8.03M

Technical Indicators

50-Day SMA	$3.69
200-Day SMA	$9.73
RSI (14)	22.70
Beta	-2.08
52-Week High	$22.20
52-Week Low	$2.20

Volume Today	28.21K
Avg Daily Volume (30D)	24.00K
Relative Volume	1.18x
Volatility (10D)	75.07
Volatility (30D)	118.01
Free Float	96.04%

Analyst Consensus

BUY

Current Price $2.29

Mean Target $56.67

52W Low$2.20 52W High$22.20

Current

Target

$2.20 $22.20

Current Analyst target

+2,374.53% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG004M23R72

ISINUS31447E2046

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateAug 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.